0000000000315785

AUTHOR

Julie Gentil

showing 6 related works from this author

In breast cancer, are treatments and survival the same whatever a patient's age? A population-based study over the period 1998-2009

2014

Aim The present study aimed to describe treatments, relative survival and prognostic factors in breast cancer patients according to age. Methods All women with primary invasive breast cancer, diagnosed from 1998 to 2009 in the department of Cote d'Or, were retrospectively selected. Variations in treatments administered according to age ( 74 years) and period were assessed using Cochran–Armitage trend tests and χ2-tests, respectively. Prognostic factors according to age were estimated using a generalized linear model with a Poisson error structure. Results Overall, 4305 women were included. The oldest women (aged >74 years) were more likely than the youngest women to have comorbidities, adva…

Gynecologymedicine.medical_specialtyRelative survivalbusiness.industryTumor biologymedicine.medical_treatmentmedicine.diseasePopulation based studyBreast cancerInternal medicineBreast-conserving surgeryAdjuvant therapyMedicineHormone therapybusinessHormoneGeriatrics & Gerontology International
researchProduct

Population-based study of ovarian cancer in Côte d'Or: prognostic factors and trends in relative survival rates over the last 20 years

2010

Abstract Background The aim of this population-based study was to assess independent prognostic factors in ovarian cancer using relative survival (RS) and to investigate changes in RS rates from 1982 to 2005. Methods Data on 748 patients with ovarian cancer were provided by the Côte d'Or gynaecologic cancer registry. The RS was estimated using a generalized linear model with a Poisson error structure. Relative survival and its 95% confidence interval (CI) were described at the following specific time points 1, 3 and 5 years. The effect of prognostic factors on survival was assessed with multivariate analyses of RS. Results The median follow-up was 12 years. The RS rates at 1, 3 and 5 years …

AdultOncologymedicine.medical_specialtyCancer ResearchMultivariate analysisAdolescentPopulationMedical Oncologylcsh:RC254-282Internal medicinemedicineGeneticsHumansRegistriesChildeducationSurvival rateAgedAged 80 and overOvarian NeoplasmsGynecologyeducation.field_of_studyRelative survivalbusiness.industryCancerMiddle AgedPrognosislcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseaseConfidence intervalSurvival RateSerous fluidTreatment OutcomeOncologyFemaleFranceOvarian cancerbusinessResearch ArticleBMC Cancer
researchProduct

Dépistage du cancer du sein dans treize départements français

2015

Resume Objectif L’objectif de ce travail etait de decrire la participation au depistage organise (DO) et la demarche de detection par mammographie individuelle (MI) en 2010–2011 dans 13 departements francais. Methodes L’analyse a porte sur les donnees de 622 382 femmes âgees de 51 a 74 ans invitees au DO du cancer du sein en 2010–2011. Le type de mammographie realisee a ete etudie selon l’âge, le regime d’Assurance maladie, la ruralite et le niveau socio-economique du lieu de residence. L’analyse a egalement permis de cartographier et d’analyser les zones etudiees en fonction de la defavorisation socio-economique et de la participation au depistage. Resultats Une mammographie de DO ou indiv…

Cancer ResearchOncologyRadiology Nuclear Medicine and imagingHematologyGeneral MedicineBulletin du Cancer
researchProduct

Population-based study of breast cancer in older women: prognostic factors of relative survival and predictors of treatment

2012

Abstract Background A large proportion of women with breast cancer (BC) are elderly. However, there is a lack of information regarding BC prognostic factors and care in this population. The aims of this study were to assess the prognostic factors of relative survival (RS) among women with BC aged ≥ 75 years old and to identify the predictive factors of treatments administered to this population. Methods A population-based study was performed using data from the Cote d’Or breast and gynaecological cancer registry. Women aged 75 years and older with primary invasive BC and resident in Cote d’Or at the time of diagnosis made between January 1998 and December 2008 were retrospectively selected.…

Cancer Researchmedicine.medical_treatmentComorbidityBreast cancerBreast-conserving surgeryRegistriesMastectomyAged 80 and overeducation.field_of_studyPredictors of treatmentRelative survivalPrognosislcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensCombined Modality TherapyTreatment OutcomeOncologyPopulation SurveillanceHypertensionFemaleFranceMastectomyResearch Articlemedicine.medical_specialtyPopulationBreast NeoplasmsPrognostic factorsRelative survivallcsh:RC254-282Breast cancerDrug TherapyInternal medicineDiabetes MellitusmedicineAdjuvant therapyGeneticsHumansObesityElderly womeneducationSurvival analysisAgedNeoplasm StagingRetrospective StudiesGynecologyRadiotherapybusiness.industrymedicine.diseaseSurvival AnalysisLogistic ModelsMultivariate AnalysisHormone therapybusinessFollow-Up StudiesBMC Cancer
researchProduct

For patients with breast cancer, geographic and social disparities are independent determinants of access to specialized surgeons. A eleven-year popu…

2012

Abstract Background It has been shown in several studies that survival in cancer patients who were operated on by a high-volume surgeon was better. Why then do all patients not benefit from treatment by these experienced surgeons? The aim of our work was to study the hypothesis that in breast cancer, geographical isolation and the socio-economic level have an impact on the likelihood of being treated by a specialized breast-cancer surgeon. Methods All cases of primary invasive breast cancer diagnosed in the Côte d’Or from 1998 to 2008 were included. Individual clinical data and distance to the nearest reference care centre were collected. The Townsend Index of each residence area was calcul…

AdultRural PopulationCancer Researchmedicine.medical_specialtyGeographical isolationBreast Neoplasms[SDV.CAN]Life Sciences [q-bio]/CancerPopulation basedlcsh:RC254-282Health Services Accessibility[ SDV.CAN ] Life Sciences [q-bio]/Cancer03 medical and health sciences0302 clinical medicineBreast cancer[SDV.CAN] Life Sciences [q-bio]/CancerSurgical oncologyGeneticsmedicineHumans030212 general & internal medicineRegistriesHealthcare DisparitiesAgedNeoplasm StagingGynecologybusiness.industryMultilevel modelCancerMiddle Agedlcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensmedicine.diseasePrognosis3. Good healthsurgical procedures operativeOncologySocioeconomic Factors030220 oncology & carcinogenesisFamily medicineMultilevel AnalysisNeoplasm stagingFemalebusinessRural populationResearch Article
researchProduct

Breast cancer in men in Cote d'Or (France): epidemiological characteristics, treatments and prognostic factors

2012

Breast cancer in men is rare, and clinical trials are thus not feasible. This study aimed to describe the epidemiological characteristics, treatment and prognostic factors of breast cancer in men. A population-based study was performed using data from the Cote d'Or breast and gynaecological cancer registry. Data on male breast cancer diagnosed from 1982 to 2008 were provided. Relative survival rates were estimated at 5 years according to the characteristics of the patient and tumour, and treatment. Prognostic factors of survival in men with breast cancer were identified using a generalised linear model. Seventy-five men with invasive breast cancer were registered. Mean age at diagnosis was …

Oncologymedicine.medical_specialtyeducation.field_of_studyRelative survivalbusiness.industrymedicine.medical_treatmentPopulationmedicine.diseaseRadiation therapyBreast cancerOncologyInternal medicineMale breast cancerEpidemiology of cancermedicineHormone therapybusinesseducationSurvival analysisEuropean Journal of Cancer Care
researchProduct